Roopal Thakkar
Vermogen: 12 M $ op 31-05-2026
Vermogen: 12 M $ op 31-05-2026
Roopal Thakkar is currently Chief Scientific Officer, Executive VP-R&D at AbbVie, Inc. since 2024.
Formerly, Dr. Thakkar was Chief Medical Officer & Senior Vice President at Global Therapeutics, Inc. Education includes an undergraduate degree from the University of Michigan and a doctorate from Wayne State University School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-03-2026 | 55.374 ( 0% ) | 12 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ABBVIE INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2003 |
| Bedrijven | Functie | Einde |
|---|---|---|
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Commercial Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wayne State University School of Medicine
Wayne State University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau